Urolithin A for muscle and mitochondria: what the trials actually show
Urolithin A is a compound your gut bacteria make from foods like pomegranate and walnuts, and it's sold as a mitochondria-supporting supplement (commonly as Mitopure). The best human trial found it genuinely improved muscle strength, but the specific outcome the study was designed to prove — power output — didn't hit statistical significance. A newer trial in athletes found it eased recovery but didn't improve actual performance. It's a real, active area of research, not a settled win.
Urolithin A is a gut-bacteria metabolite of ellagitannins (found in pomegranate, walnuts, and berries) that activates mitophagy — the recycling of damaged mitochondria. Two placebo-controlled human RCTs exist. The larger one, in middle-aged adults, found a real, statistically significant ~12% improvement in muscle strength, plus lower inflammation and mitochondrial-efficiency markers — but missed its own primary endpoint (peak power output). A newer trial in trained distance runners found lower perceived exertion and less exercise-induced muscle damage, but no significant improvement in actual running performance. No trial has measured lifespan or a hard disease outcome.
- Singh et al. 2022 (Cell Rep Med) — middle-aged adults, 4-month RCT: muscle strength improved ~12% (statistically significant), but the trial's stated primary endpoint, peak power output, was not significantly improved.
- The same trial found clinically meaningful gains in aerobic endurance (VO2peak) and the 6-minute walk test, plus lower CRP and plasma acylcarnitines (inflammation and mitochondrial-efficiency markers).
- Whitfield et al. 2025 (Sports Med) — highly trained male distance runners, 4-week RCT: no significant improvement in actual running performance (3000m time trial), but lower perceived exertion and reduced post-exercise muscle-damage markers.
- A 2021 mechanistic review confirms urolithin A has been shown safe up to 2,500mg/day in a clinical trial.
- No trial in any population has measured lifespan, healthspan, or a hard age-related disease outcome.
The main human trial: real strength gain, missed primary endpoint
The trial most often cited for urolithin A is a randomized, placebo-controlled study in middle-aged adults, published in Cell Reports Medicine in 2022. Participants took urolithin A at two different doses for four months.
Singh et al. 2022 — what was measured
| Outcome | Result |
|---|---|
| Peak power output (the trial's stated primary endpoint) | Not significantly improved |
| Muscle strength | ~12% improvement — statistically significant |
| Aerobic endurance (VO2peak) and 6-minute walk test | Clinically meaningful improvement |
| Plasma acylcarnitines and C-reactive protein | Significantly lower (higher mitochondrial efficiency, less inflammation) |
| Mitophagy/mitochondrial-metabolism proteins in muscle biopsies | Significant increase |
A newer trial in trained athletes: recovery, not performance
A 2025 trial in Sports Medicine tested urolithin A (1,000mg/day for 4 weeks) in highly trained male distance runners during an altitude training camp — a different, fitter population than the middle-aged trial above.
Whitfield et al. 2025 — what was measured
| Outcome | Result |
|---|---|
| 3000m time-trial running performance | Not significantly improved vs. placebo |
| Rating of perceived exertion after the time trial | Significantly lower with urolithin A |
| Creatine kinase (a muscle-damage marker) | Significantly reduced vs. placebo |
| VO2max | Larger within-group increase than placebo, but the between-group difference wasn't statistically significant |
| Skeletal-muscle mitophagy markers | A medium-sized effect, not statistically significant |
Dose and safety
- A 2021 mechanistic review reports urolithin A has been shown safe at doses up to 2,500mg/day in a clinical trial.
- The two RCTs above used lower doses over 4 weeks to 4 months (1,000mg/day in the athlete trial; two unspecified doses in the middle-aged trial) — neither tested the 2,500mg/day ceiling for efficacy.
- Most commercial products (commonly sold as Mitopure) provide 500mg per serving.
- No trial has run long enough to establish safety data beyond several months of continuous use.
Frequently asked questions
Does urolithin A actually improve muscle strength?
The best RCT found a statistically significant ~12% improvement in muscle strength in middle-aged adults over 4 months. That result is real, but it was a secondary finding — the trial's primary endpoint, peak power output, was not significantly improved. Treat the strength result as promising, not definitive.
Does urolithin A improve athletic performance?
Not demonstrated. A 2025 trial in trained distance runners found no significant improvement in actual running performance (a 3000m time trial), though it did find lower perceived exertion and reduced muscle-damage markers after hard exercise — real recovery benefits, just not a performance gain.
What dose of urolithin A should I take?
The human RCTs used 1,000mg/day (4 weeks, athletes) or two lower unspecified doses (4 months, middle-aged adults). A separate safety review found no issues up to 2,500mg/day, but that higher dose hasn't itself been tested for effectiveness. Most commercial products provide 500mg per serving.
Does urolithin A extend lifespan?
Not tested. No human trial has measured lifespan, healthspan, or a hard age-related disease outcome from urolithin A. The evidence that exists is about muscle strength, exercise recovery, and mitochondrial biomarkers over weeks to months — a plausible mechanism, not a demonstrated longevity effect.
Keep reading
- Creatine and aging: the best-documented compound in longevity
The compound urolithin A is most often compared against — with a much larger and more consistent trial base.
- Taurine and longevity: what the human evidence actually shows
Another compound with a famous headline result and a narrower human evidence base than the marketing suggests.
More in Supplements
- Best sleep aids, ranked by evidence.
Melatonin has modest evidence for insomnia and strong evidence for jet lag; magnesium, glycine, weighted blankets, valerian and CBD ranked on what each shows.
- Taurine and longevity: what the human evidence actually shows
The study that made taurine famous extended lifespan in mice, not humans. What the actual human trials show, the dose studied, and who should be careful.
- Creatine and aging: the best-documented compound in longevity
Creatine has more human trials than any other longevity supplement, at a fraction of the price. What's proven for aging, the dose, and who should be careful.
- Which science-backed supplements can safely extend life?
Correcting vitamin D deficiency ranks first among supplements safely backed by human evidence; NMN, resveratrol and most others lack human trials.
- Best anti aging supplements to extend life naturally.
Correcting a real vitamin D or B12 deficiency ranks first, well studied and safe; omega-3, creatine and collagen follow, while NMN and resveratrol lack it.
- Complete supplement stack designed to extend lifespan effectively.
Correcting deficiencies, omega-3 in specific groups, creatine, fibre and protein make up the only stack with genuine human evidence for extending lifespan.